MedPath

Study for investigating the secretion of incretin and glucagon in pregnant women with gestational diabetes mellitus

Not Applicable
Recruiting
Conditions
Gestational Diabetes Mellitus
Registration Number
JPRN-UMIN000010573
Lead Sponsor
Hamamatsu University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
250
Inclusion Criteria

Not provided

Exclusion Criteria

The woman who has diabetes before pregnancy; has overt diabetes during pregnancy; uses the drug affecting blood glucose; has GAD65 antibody

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The secretion of incretin, and glucagon during 75g oral glucose tolerance test
Secondary Outcome Measures
NameTimeMethod
Identification of risk factor of gestational diabetes mellitus that needs insulin therapy or not
© Copyright 2025. All Rights Reserved by MedPath